Physician

Alcides E Gil-Acosta, M.D.

According to 2025 Medicare claims, Alcides Gil-Acosta, M.D. (NPI: 1487614343) practices pulmonary disease in the Battle Creek, MI market, with the plurality of this provider's patient population coming from Calhoun, MI. This provider's primary affiliated billing organization is ELLA E M BROWN CHARITABLE CIRCLE (NPI: 1366591794; TIN: 381368347) and primary practice location at 49068-1117. Gil-Acosta is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974), participating under the MSSP model.

Gil-Acosta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 235 traditional Medicare patients, billed 1,104 HCPCS/CPT codes, and received $44,101 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,340 prescription claims across 291 beneficiaries totaling $1,350,163 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 982 claims. Open Payments data shows 2 records totaling $37. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $139,727 to $44,101. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $981,102 and ending at $1,350,163. For DME billing, reported payments moved from a higher plateau to a lower plateau, from $120,836 to $42,339.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	560	2,115	$139,727
2016	590	2,020	$117,305
2017	569	2,024	$115,785
2018	478	1,630	$76,498
2019	463	1,749	$78,973
2020	367	1,126	$62,561
2021	359	1,268	$85,852
2022	288	915	$56,741
2023	235	698	$39,818
2024	235	1,104	$44,101

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	295	2,229	$981,102
2016	314	2,654	$1,762,899
2017	367	2,888	$1,931,428
2018	314	2,588	$1,716,087
2019	291	2,475	$2,262,858
2020	275	2,502	$1,229,238
2021	276	2,286	$1,178,147
2022	261	2,143	$1,089,438
2023	276	1,928	$999,663
2024	291	2,340	$1,350,163

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	447	2,456	$199,509
2016	476	2,451	$166,963
2017	550	2,657	$182,507
2018	449	2,365	$160,531
2019	406	1,986	$110,800
2020	246	1,513	$112,643
2021	178	1,188	$105,727
2022	230	1,063	$105,285
2023	151	1,099	$77,007
2024	181	982	$56,538

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	126	231	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	139	209	$47
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	154	254	$12
94726	Test to determine lung volumes using sensors	87	89	$9
94729	Test to examine how well the lungs exchange gases	85	87	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	532	19,230	$397,443
Ofev	Nintedanib Esylate	27	810	$332,775
Glassia	Alpha-1-Proteinase Inhibitor	13	364	$141,403
Prolastin C	Alpha-1-Proteinase Inhibitor	11	294	$125,851
Breo Ellipta	Fluticasone/Vilanterol	118	4,860	$62,177

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	28	237	$19,069
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	16	$13,964
A7031	Face mask interface, replacement for full face mask, each	N	11	23	$2,502
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	15	145	$2,465
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	45	$2,464

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$37	Mylan Specialty L.P.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alcides E. Gil-Acosta, M.D.?

Tedicare shows public-source Medicare data for Alcides E. Gil-Acosta, M.D. (NPI 1487614343), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alcides E. Gil-Acosta, M.D. have ACO affiliation data?

Alcides E. Gil-Acosta, M.D. is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974).

What billing organization is linked to Alcides E. Gil-Acosta, M.D.?

Alcides E. Gil-Acosta, M.D. is linked to ELLA E M BROWN CHARITABLE CIRCLE (billing NPI 1366591794) in the available physician profile data.

Does Alcides E. Gil-Acosta, M.D. have Open Payments data?

Alcides E. Gil-Acosta, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.